News Industry News Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure February 25, 2019
News Industry News Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure October 26, 2015
News Industry News Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes August 26, 2015
News Industry News Boston Scientific Announces CE Mark For MRI Compatible Labeling For ICD And CRT-D Systems August 24, 2015